No abstract available
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use
-
Axilla
-
Brentuximab Vedotin
-
Disease Progression
-
Hodgkin Disease / complications
-
Hodgkin Disease / drug therapy
-
Hodgkin Disease / pathology
-
Hodgkin Disease / physiopathology*
-
Humans
-
Immunoconjugates / therapeutic use
-
Male
-
Neoplasm Staging
-
Pruritus / etiology
-
Skin Neoplasms / prevention & control
-
Skin Neoplasms / secondary*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Immunoconjugates
-
Brentuximab Vedotin